Subsidy Information and Financing Scheme MSHLNelarabine Injection 250 mg/50 mL Treatment of T-cell acute lymphoblastic leukaemia and T-cell lymphoblastic lymphoma that has not re... See all × MSHLNelarabine Injection 250 mg/50 mL Treatment of T-cell acute lymphoblastic leukaemia and T-cell lymphoblastic lymphoma that has not responded to or has relapsed following treatment with at least 2 chemotherapy regimens.